Items 1 ~ 8 of 279, Page 1 of 35
Abbott Announces New Data That Shows Artificial Intelligence Technology Can Help Doctors Better Determine Which Patients are Having a Heart Attack
New research found Abbott's algorithm created through machine learning could give doctors a more individualized calculation, leveraging factors such a...
Abbott Launches World''s First Pivotal Trial to Test New Approach for Repairing Leaky Tricuspid Heart Valves
TRILUMINATE Pivotal trial is the world's first randomized clinical trial to evaluate transcatheter tricuspid valve repair in patients with severe tric...
Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality
Expanded TAVR Indication to Younger, More Active Patients Signals Groundbreaking Shift in the Future Treatment of Heart Valve Disease
Medtronic Partners with Viz.ai to Accelerate Adoption of New Artificial Intelligence Software in U.S. Stroke Centers
Technology Has the Potential to Save Crucial Time and Increase Access to Lifesaving Stroke Treatments
FDA Approves Merck’s RECARBRIO™ (imipenem, cilastatin, and relebactam) For the Treatment of Adults with Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections Where Limited or No Alternative Treatment Options Are Available
Abbott Receives U.S. Approval of Next-Generation MitraClip™, Bringing New Enhancements to Abbott''s Leading MitraClip Platform
U.S. approval for MitraClip G4 offers a next-generation approach to mitral valve repair / G4 includes new clip sizes and an enhanced leaflet grasping ...
Medtronic HeartWare(TM) HVAD(TM) Implanted via Less Invasive Thoracotomy Shows 95 Percent Freedom from Disabling Stroke at Two Years
Company Plans Global Registry of HVAD Thoracotomy Implants to Advance Therapy Knowledge
Medtronic Supports CMS Ruling on TAVR National Coverage Determination
Medtronic plc (NYSE:MDT) today issued the following statement regarding the final decision memo updating the TAVR National Coverage Determination (NCD...